Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chinook Therapeutics Inc (NQ: KDNY )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Chinook Therapeutics Inc

< Previous 1 2 3 Next >
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
Via Benzinga
Expert Ratings for Chinook Therapeutics
Via Benzinga
What 6 Analyst Ratings Have To Say About Chinook Therapeutics
Via Benzinga
What To Know About Guggenheim's Downgrade of Chinook Therapeutics
Via Benzinga
Health Care Company Novartis Announces Merger With Chinook Therapeutics
Via Benzinga
Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire
Chinook Therapeutics has a history of being opportunistic. Now, it's joining forces with Novartis. 
Via Investor's Business Daily
Why Shares of Vera Therapeutics Jumped Tuesday
The company announced early phase 2 trials information regarding its lead therapy. 
Via The Motley Fool
2 Surging Healthcare Stocks With More Fuel in the Tank
These stocks climbed 74% and 78% over the past month and there could be more gains ahead. 
Via The Motley Fool
Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review
Stocks kept powering higher despite, but the Nasdaq is looking extended. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
Via Benzinga
KDNY Stock Alert: Why Short Seller Muddy Waters Is Betting Against Chinook
Chinook Therapeutics is about to be acquired by Novartis. News of this deal hasn't stopped Muddy Waters from betting against KDNY stock. 
Via InvestorPlace
Nasdaq Gains 1%; US Budget Deficit Widens In May
U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.19% to 33,939.74 while the NASDAQ rose 1% to 13,391.54. The S&P 500,... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Stocks Sport Midday Leads As Busy Week Begins
Stocks are modestly higher this afternoon amid hopes of a dovish Fed, with the central bank's policy decision due out Wednesday. 
Via Talk Markets
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord. 
Via Benzinga
Why Shares of Chinook Therapeutics Skyrocketed On Monday
The company, which specializes in treating kidney diseases, agreed to a buyout offer. 
Via The Motley Fool
Crude Oil Drops Sharply; Chinook Therapeutics Shares Spike Higher
U.S. stocks traded higher midway through trading, with Dow Jones gaining over 40 points on Monday. The Dow traded up 0.12% to 33,919.07 while the NASDAQ rose 0.49% to 13,323.71. The S&P 500, also rose,... 
Via Benzinga
Chinook Therapeutics Launches Almost 60% On Novartis' $3.5 Billion Takeover
Novartis will pay $3.5 billion to buy the kidney disease-focused biotech company. 
Via Investor's Business Daily
XPeng's New EV Is a Hit, but This Biotech Stock Is Leaving It in the Dust
Find out more about two big winners Monday morning. 
Via The Motley Fool
US Stocks Open Higher; Nasdaq Rises Over 50 Points
U.S. stocks traded higher this morning, with Nasdaq Composite gaining over 50 points on Monday. Following the market opening Monday, the Dow traded up 0.21% to 33,948.78 while the NASDAQ rose 0.47% to... 
Via Benzinga
Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories
Reuters Broadcom Most Likely To Receive EU Approval For $61B VMware Merger 
Via Benzinga
Why Is Oncorus (ONCR) Stock Down 27% Today?
Oncorus (ONCR) stock is taking a beating on Monday after revealing plans for a vote during an upcoming special shareholder meeting. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Is Chinook Therapeutics (KDNY) Stock Up 58% Today?
Chinook Therapeutics (KDNY) stock is rocketing higher on Monday after the company announced it's being acquired by Novartis AG (NVS). 
Via InvestorPlace
Why Oncorus Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Gainers Auddia Inc. (NASDAQ: AUUD) shares rose 103.2% to $0.8809 in pre-market trading after gaining around 9% on Friday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning! 
Via InvestorPlace
Why Are Chinook Therapeutics Shares Trading Higher Today
Novartis AG (NYSE: NVS) has agreed to acquire Chinook Therapeutics Inc (NASDAQ: KDNY) for $40 per share in cash,  
Via Benzinga
Nasdaq, S&amp;P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.